Jun. 6 at 4:21 PM
$PYPD I own 20,000 shares. I would prefer selling 5,000 shares around
$10 before FDA decision or stock offering to decrease my own risk. And then another 5,000 shares around
$15. And then leaving 10,000 shares over
$20-30 levels. FDA approval is very likely bc the clinical data is very robust (all primary and secondary endpoints). There is always a risk for CMC issues when FDA makes inspection. But mgt has been very strict and humble, and they have been approved by domestic authority. So all in all, FDA approval very is likely.
